RxDoctor Payments Data

Daniel St Amour, NP

Adult Health · Woodhaven, MINPI 1164933354

Payments from drug & device makers

$2,294in general payments, 2019–2025

Across 122 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Alkermes, Inc.$287
  • Vanda Pharmaceuticals Inc.$264
  • Otsuka America Pharmaceutical, Inc.$196
  • Indivior Inc.$86
  • Braeburn Inc.$48
  • plus $64 from 3 others

What the payments were for

  • Food & beverage$2,294100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,294 in reported general payments places this provider in the 80th percentile of 527 adult health providers in Michigan.

See all adult health providers in Michigan

Medicare billing

Part B allowed, 2024
$100,032
Medicare patients
46
Services billed
824

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate17$41,949
Abilify MaintenaAripiprazole13$34,074
Aripiprazole17$6,550
Lurasidone Hcl12$1,966
Bupropion XlBupropion Hcl36$1,101
Clonazepam56$454
Quetiapine Fumarate57$440
Lamotrigine57$375
Duloxetine Hcl12$267
Hydroxyzine Hcl17$218
Buspirone Hcl37$218
Venlafaxine Hcl ErVenlafaxine Hcl22$204
Mirtazapine27$180
Trazodone Hcl33$129
Sertraline Hcl18$60

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$21$41,94917 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$196$34,07413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 527 adult health providers in Michigan.

Other adult health in Woodhaven

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →